title: Absence of nigral degeneration in aged parkin/DJ-1/PINK1 triple knockout mice.
abstract: Recessively inherited loss-of-function mutations in the parkin, DJ-1, or PINK1 gene are linked to familial cases of early-onset Parkinson's diseases (PD), and heterozygous mutations are associated with increased incidence of late-onset PD. We previously reported that single knockout mice lacking Parkin, DJ-1, or PINK1 exhibited no nigral degeneration, even though evoked dopamine release from nigrostriatal terminals was reduced and striatal synaptic plasticity was impaired. In this study, we tested whether inactivation of all three recessive PD genes, each of which was required for nigral neuron survival in the aging human brain, resulted in nigral degeneration during the lifespan of mice. Surprisingly, we found that triple knockout mice lacking Parkin, DJ-1, and PINK1 have normal morphology and numbers of dopaminergic and noradrenergic neurons in the substantia nigra and locus coeruleus, respectively, at the ages of 3, 16, and 24 months. Interestingly, levels of striatal dopamine in triple knockout mice were normal at 16 months of age but increased at 24 months. These results demonstrate that inactivation of all three recessive PD genes is insufficient to cause significant nigral degeneration within the lifespan of mice, suggesting that these genes may be protective rather than essential for the survival of dopaminergic neurons during the aging process. These findings also support the notion that mammalian Parkin and PINK1 may function in the same genetic pathway as in Drosophila.
authors.affiliation: Center for Neurologic Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusets, USA.
authors.forename: Tohru
authors.initials: T
authors.lastname: Kitada
authors.forename: Youren
authors.initials: Y
authors.lastname: Tong
authors.forename: Clement A
authors.initials: CA
authors.lastname: Gautier
authors.forename: Jie
authors.initials: J
authors.lastname: Shen
mesh_terms: D000367:Age Factors; D000818:Animals; D002452:Cell Count / Q000379:methods; D004298:Dopamine / Q000378:metabolism; D004563:Electrochemistry / Q000379:methods; D008125:Locus Coeruleus / Q000473:pathology; D051379:Mice; D018345:Mice, Knockout; D009410:Nerve Degeneration / Q000235:genetics*; D009474:Neurons / Q000502:physiology*; D008771:Nordefrin / Q000378:metabolism; D015513:Oncogene Proteins / Q000172:deficiency*; D054464:Peroxiredoxins; D000071617:Protein Deglycase DJ-1; D011494:Protein Kinases / Q000172:deficiency*; D013378:Substantia Nigra / Q000473:pathology*; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism; D044767:Ubiquitin-Protein Ligases / Q000172:deficiency*; D000099202:PTEN-Induced Putative Kinase
chemical_list: D004298:Dopamine; D008771:Nordefrin; D015513:Oncogene Proteins; D054464:Peroxiredoxins; D000071617:Protein Deglycase DJ-1; D011494:Protein Kinases; D014446:Tyrosine 3-Monooxygenase; D044767:Ubiquitin-Protein Ligases; D000099202:PTEN-Induced Putative Kinase; C111567:parkin protein; C503466:PARK7 protein, mouse
references.citation: J Neurochem. 2008 Oct;107(1):171-85
references.pmid: 18691389
references.citation: PLoS One. 2008 Jun 18;3(6):e2455
references.pmid: 18560593
references.citation: Neuron. 2005 Feb 17;45(4):489-96
references.pmid: 15721235
references.citation: Mov Disord. 2008 Jul 30;23(10):1461-5
references.pmid: 18546294
references.citation: J Neurochem. 2009 Jul;110(2):613-21
references.pmid: 19457102
references.citation: EMBO Rep. 2004 Feb;5(2):213-8
references.pmid: 14749723
references.citation: Development. 2004 May;131(9):2183-94
references.pmid: 15073152
references.citation: Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):2174-9
references.pmid: 15684050
references.citation: Brain Dev. 2000 Sep;22 Suppl 1:S87-91
references.pmid: 10984666
references.citation: Science. 2004 May 21;304(5674):1158-60
references.pmid: 15087508
references.citation: Neurology. 2005 Jun 14;64(11):1958-60
references.pmid: 15955954
references.citation: J Biol Chem. 2003 Oct 31;278(44):43628-35
references.pmid: 12930822
references.citation: Curr Biol. 2005 Sep 6;15(17):1572-7
references.pmid: 16139213
references.citation: Science. 2003 Jan 10;299(5604):256-9
references.pmid: 12446870
references.citation: Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10793-8
references.pmid: 16818890
references.citation: Hum Mol Genet. 2005 Jan 1;14(1):71-84
references.pmid: 15525661
references.citation: Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5215-20
references.pmid: 15784737
references.citation: Curr Biol. 2005 Sep 6;15(17):1578-82
references.pmid: 16139214
references.citation: Ann Neurol. 2002 Feb;51(2):253-6
references.pmid: 11835383
references.citation: Biochem Biophys Res Commun. 2003 Dec 26;312(4):1342-8
references.pmid: 14652021
references.citation: Rinsho Shinkeigaku. 1993 May;33(5):491-6
references.pmid: 8365054
references.citation: Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14807-12
references.pmid: 17766438
references.citation: Neurology. 1994 Mar;44(3 Pt 1):437-41
references.pmid: 8145912
references.citation: Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13670-5
references.pmid: 16155123
references.citation: J Biol Chem. 2007 May 4;282(18):13680-91
references.pmid: 17331951
references.citation: Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11364-9
references.pmid: 18687901
references.citation: J Biol Chem. 2004 Apr 30;279(18):18614-22
references.pmid: 14985362
references.citation: Hum Mol Genet. 2003 Sep 15;12(18):2277-91
references.pmid: 12915482
references.citation: Neurology. 1973 Mar;23(3):239-44
references.pmid: 4735177
references.citation: Nature. 2006 Jun 29;441(7097):1162-6
references.pmid: 16672981
references.citation: Mov Disord. 2003 Jul;18(7):751-7
references.pmid: 12815653
references.citation: Hum Mol Genet. 2005 Jul 15;14(14):2063-73
references.pmid: 15944198
references.citation: Neurosci Lett. 2003 Feb 13;337(3):123-6
references.pmid: 12536039
references.citation: Nature. 2006 Jun 29;441(7097):1157-61
references.pmid: 16672980
references.citation: J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
references.pmid: 1564476
references.citation: Nature. 1998 Apr 9;392(6676):605-8
references.pmid: 9560156
references.citation: Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4078-83
references.pmid: 12642658
references.citation: Proc Natl Acad Sci U S A. 2007 Jul 3;104(27):11441-6
references.pmid: 17563363
references.citation: Hum Mol Genet. 2006 Jun 1;15(11):1816-25
references.pmid: 16632486
references.citation: Ann N Y Acad Sci. 2003 Jun;991:120-31
references.pmid: 12846981
references.citation: Mol Neurodegener. 2007 May 29;2:10
references.pmid: 17535435
references.citation: Neuroscience. 2000;101(4):1063-9
references.pmid: 11113355
references.citation: J Neurosci Res. 2009 Jan;87(1):123-9
references.pmid: 18711745